Please check your internet connection and try again.
# Sompraz hp
## Overview
Sompraz hp is a combination medication containing pantoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori* (*H. pylori*). Pantoprazole is a proton pump inhibitor (PPI), amoxicillin is a penicillin-class antibiotic, and clarithromycin is a macrolide antibiotic.
## Primary Indications
Eradication of *Helicobacter pylori* in patients with peptic ulcer disease.
## Adult Dosing
The typical adult regimen is one capsule (containing pantoprazole 40 mg, amoxicillin 500 mg, and clarithromycin 500 mg) taken twice daily for 7 to 14 days.
Alternatively, a common regimen is:
* Pantoprazole 40 mg orally twice daily
* Amoxicillin 1000 mg orally twice daily
* Clarithromycin 500 mg orally twice daily
The duration of treatment is typically 10 to 14 days. Specific duration may vary based on local guidelines and patient factors.
## Pediatric Dosing
Dosing for Sompraz hp in pediatric patients is not well-established and should be determined by a specialist based on weight and clinical assessment. Individual components have pediatric use, but fixed-dose combinations are generally not recommended for children without specific guidance.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment is typically required for pantoprazole. For amoxicillin and clarithromycin, dose adjustment may be necessary in severe renal impairment. Refer to individual drug monographs for specific guidance.
* **Hepatic Impairment:** No dose adjustment is typically required for pantoprazole in mild to moderate hepatic impairment. Use with caution in severe hepatic impairment. Dose adjustment for clarithromycin may be necessary in hepatic impairment. Refer to individual drug monographs.
## Contraindications
* Hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or other macrolides, penicillins, or any component of the formulation.
* History of severe immediate hypersensitivity reactions to beta-lactams.
* Use in patients with a history of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
* Concomitant use with ergotamine or dihydroergotamine.
* Use in patients with known QT prolongation, a history of torsades de pointes, hypokalemia, hypomagnesemia, or clinically significant bradycardia.
## Adverse Effects
Common adverse effects may include diarrhea, nausea, abdominal pain, taste disturbances, headache, rash, and vulvovaginal candidiasis. Serious adverse effects can include severe allergic reactions, *Clostridioides difficile*-associated diarrhea, liver dysfunction, and QT prolongation.
## Key Drug Interactions
* **Pantoprazole:** Can decrease the absorption of drugs requiring an acidic environment (e.g., ketoconazole, itraconazole, atazanavir). May increase levels of drugs metabolized by CYP enzymes (though less significant than some other PPIs).
* **Clarithromycin:** Potent inhibitor of CYP3A4. Can increase serum concentrations of drugs metabolized by CYP3A4, such as simvastatin, lovastatin, atorvastatin, carbamazepine, cyclosporine, tacrolimus, and warfarin. Contraindicated with colchicine, ergotamine, and dihydroergotamine. May interact with statins, leading to myopathy.
* **Amoxicillin:** Can decrease the effectiveness of oral contraceptives. Probenecid can decrease the renal excretion of amoxicillin.
## Monitoring
* Monitor for signs and symptoms of hypersensitivity reactions.
* Monitor for efficacy in *H. pylori* eradication (e.g., urea breath test, stool antigen test, or biopsy-based tests after completion of therapy).
* Monitor for adverse effects, particularly diarrhea, gastrointestinal upset, and rash.
* Monitor liver function tests if significant hepatic impairment is present or symptoms develop.
## Clinical Pearls
* Administer the combination therapy as prescribed to ensure adequate *H. pylori* eradication.
* Patients should be advised to complete the full course of treatment even if symptoms improve.
* The combination should be taken with food to minimize gastrointestinal upset.
* Consider the potential for antibiotic resistance when prescribing clarithromycin.
* In patients with penicillin allergy, alternative *H. pylori* eradication regimens should be considered.
***
*Disclaimer: This information is intended for healthcare professionals and does not substitute for professional medical judgment. Always consult the most current prescribing information, product literature, and relevant clinical guidelines before making any treatment decisions. The information provided here may not be exhaustive and may not reflect all possible interactions, contraindications, or adverse effects.*
